The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (5 analysts) rates it none, with a mean price target of $34.
ConnectOne Bancorp, Inc.
CNOB · Nasdaq · USD · Market cap $1.6B · 750 employees
ConnectOne Bancorp, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-07
Screened 2026-09-07 · the tape above runs as of 19:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
ConnectOne Bancorp, Inc. holds its Markdown at $32.31. The statistical read favours the sellers, held for 41 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 41 days |
| Price at the screen | $32.31 |
| Valuation | 10.03 trailing · 8.81 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.02 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: bank
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: bank | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. A 17.6% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +15% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBanks Look Ordinary Until Ethics Draw the Line
Picture a regional lender handing out loans to small businesses and local professionals across the United States. The operation generates steady revenue and posts a 26 percent profit margin, yet none of that matters once the ethical screen flags the entire sector as off limits.
We pass for that single reason. The business shows 66 percent revenue growth and trades at 9.2 times forward earnings with a 7 percent return on equity, but our rules leave no room for banks regardless of valuation or analyst targets around 36 dollars.
The low ROE already signals limited returns on shareholder capital, and any cyclical upswing in lending could reverse quickly if rates or credit conditions shift. Analysis, not advice.
| Forward P/E | 8.8xcheap for a company growing this fast |
| Trailing P/E | 10.0xreasonably valued |
| EPS, trailing | 3.22 |
| EPS, forward | 3.67 |
| Revenue growth | +134.2%growing very fast |
| Profit margin | 36.1%highly profitable on every dollar of sales |
| Return on equity | 10.2%a modest return on shareholder capital |
| Dividend yield | 238.00% |
| Beta | 1.02moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 23.20 - 34.14 |
| Market cap | $1.6B |
| Employees | 750 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCNOB trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (5 analysts) rates it none, with a mean price target of $34.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 40%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (5 analysts) rates it none, with a mean price target of $34.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $29.53 | +8.0% | $0.20 | $1,087 | +8.7% |
| 2 months | $27.93 | +14.2% | $0.20 | $1,149 | +14.9% |
| 3 months | $25.26 | +26.3% | $0.20 | $1,270 | +27.0% |
| 6 months | $27.04 | +18.0% | $0.38 | $1,194 | +19.4% |
| 1 year | $22.77 | +40.1% | $0.74 | $1,433 | +43.3% |
| 2 years | $16.95 | +88.2% | $1.46 | $1,967 | +96.7% |
| 3 years | $14.72 | +116.7% | $2.15 | $2,313 | +131.3% |
| 5 years | $23.85 | +33.7% | $3.31 | $1,476 | +47.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CNOB does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.